Have your own idea? Try our Stock Screener
UPDATED Feb 20, 2025
Discover small cap German Pharmaceuticals & Biotech companies that are on the DAX. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
PA8K | €0.016 | 21.2% | -62.4% | €114.1k | n/a | n/a | n/a | n/a | ||
27N0 | €0.35 | 6.1% | -94.0% | €146.9k | n/a | n/a | n/a | n/a | ||
CNW | €0.015 | 107.1% | -18.5% | €187.1k | n/a | n/a | n/a | n/a | ||
3YX | €0.001 | 0% | -50.0% | €314.1k | n/a | n/a | n/a | n/a | ||
SBH | €0.002 | 0% | -77.8% | €419.8k | n/a | PS3.8x | n/a | n/a | ||
T5O | €0.95 | -6.0% | -71.3% | €490.1k | n/a | PS98.2x | n/a | n/a | ||
ECX | €1.12 | -2.6% | -33.9% | €980.2k | n/a | PE0.3x | n/a | n/a | ||
991 | €1.99 | 0% | 665.4% | €4.6m | n/a | PS2.6x | n/a | n/a | ||
CNW | €0.24 | 0% | -84.5% | €6.5m | n/a | PB1x | n/a | n/a | ||
0K30 | €2.18 | 0% | -53.3% | €9.7m | n/a | PS8.8x | n/a | n/a | ||
20B | €0.12 | -6.8% | -26.2% | €11.3m | n/a | PS106.2x | n/a | n/a | ||
PJ2 | €3.80 | 0% | -0.7% | €11.8m | n/a | PS43.7x | S-149.8% | n/a | ||
B8FK | €2.38 | 3.5% | -68.1% | €14.5m | n/a | PB0.9x | n/a | n/a | ||
MDG1 | €1.60 | 3.5% | -49.2% | €25.6m | €2.90 | PS3.2x | E14.1% | n/a | ||
SBX | €3.89 | -4.2% | -67.6% | €26.5m | €12.45 | PS6.9x | E106.9% | n/a | ||
T9G | €0.73 | 25.9% | 7.4% | €33.3m | €4.91 | n/a | n/a | n/a | ||
HIGH | €4.70 | 0% | -44.7% | €58.9m | €12.25 | PE265x | E112.0% | n/a | ||
VSC | €5.50 | -11.3% | -34.1% | €61.5m | n/a | PS167.1x | n/a | n/a | ||
2INV | €12.10 | 1.7% | 51.2% | €69.6m | n/a | PE13.8x | n/a | n/a | ||
7V0 | €27.40 | -2.8% | -26.3% | €82.2m | n/a | n/a | n/a | 8.2% | ||
APPH | €11.30 | 3.7% | 88.3% | €94.1m | €13.25 | PS2.3x | E78.1% | n/a | ||
93M1 | €23.60 | 4.4% | 5.8% | €96.8m | €108.00 | PE0.8x | E-65.7% | 5.1% | ||
HPHA | €2.32 | 1.8% | -24.4% | €110.0m | €10.05 | PS12.8x | E-33.0% | n/a | ||
PSG | €26.00 | -1.5% | 26.2% | €311.7m | €38.75 | PE16.6x | E14.1% | 5.2% |